Turing Biosystems
Artificial intelligence to select targets for oncology drugs. Turing Bio uses artificial intelligence to identify the origins of a disease like cancer, allowing pharmaceutical companies to develop drugs focused on the right target.
Dr. Adam Amara was a PhD in Synthetic and Systems Biology at the University of Manchester. He formed Turing Bio out of his PhD, when childhood friend Dr. Remy Boutonnet, PhD in Computer Science at the University of Grenoble, explained how his experience in automated reasoning could be used in drug design.
Dr. Adam Amara was a PhD in Synthetic and Systems Biology at the University of Manchester. He formed Turing Bio out of his PhD, when childhood friend Dr. Remy Boutonnet, PhD in Computer Science at the University of Grenoble, explained how his experience in automated reasoning could be used in drug design.
Summary
